Pulling SEC filings + quote and writing the call…

IMPINJ INC
Next earnings Jul 28, 2026 · consensus $0.82 EPS, $108M rev
Last earnings +1.0% on 2026-04-29
Quality RAIN RFID franchise with a flat year and a profit reversal — fair to own, hard to chase at 10.7x sales.
Revenue $361M · FY2025
Impinj is the clear platform leader in RAIN RFID — management's own framing (150B+ items connected, Gen2X extensions 'broadly embraced' by the industry) maps to durable share in endpoint ICs and reader systems. The financials show that franchise's quality without yet showing it has compounded into reliable earnings: FY2025 revenue slipped 1.4% to $361M after a 19% jump in FY2024, gross margin held a strong 52.5%, but operating income flipped back to roughly breakeven (-$737K) and net income swung from +$40.8M to -$10.8M. The 10-K itself flags 'a history of losses' and 'significant fluctuations in our quarterly and annual operating results' — FY2025 fits that pattern more than it breaks it.\n\nMD&A explains the air-pocket: revenue is dominated by endpoint ICs sold through partners/distributors, so Impinj has limited visibility into true end-user demand and can be whipsawed when 'major end users adjust the mix of inlay providers.' Layer on the explicit tariff/trade exposure (most ICs end up embedded in goods that move across borders) and the FY2025 wobble looks more like inventory/macro digestion than a structural break. R&D was kept at $103M (+3.8%) — they are still investing through the soft patch, which is the right call for a platform company.\n\nBalance sheet is workable but not pristine: $48M cash against $281M total convertible debt ($190M 0% 2029s + $97.5M 1.125% 2027s per the risk factors), with the 2027 tranche now sitting in current liabilities. Equity grew 40% to $209M and current ratio is healthy (~2.7x), but retained earnings are -$400M — this company has consumed a lot of capital to build its position. At $128 and a $3.87B market cap, the stock trades at 10.7x trailing sales with no current GAAP profitability and negative ROE (-5.2%); that's a price that already credits a re-acceleration. Net: a high-quality but lumpy franchise priced for resumed growth — own it, but the risk/reward doesn't justify chasing it here.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:13 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $190M | $258M | $308M | $366M | $361M |
| Gross profit | $99.0M | $138M | $152M | $189M | $190M |
| Operating income | -$37.2M | -$19.5M | -$43.5M | -$7.07M | -$737K |
| Net income | -$51.3M | -$24.3M | -$43.4M | $40.8M | -$10.8M |
| Diluted EPS | -$2.12 | -$0.95 | -$1.62 | $1.39 | -$0.37 |
| Net margin | -26.9% | -9.4% | -14.1% | 11.2% | -3.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results disclosed; routine governance with no material change
Q1 2026 10-Q; ongoing tariff and demand-visibility risks weighing on near-term revenue
Q1 2026 10-Q; ongoing tariff and demand-visibility risks weighing on near-term revenue
Proxy: routine board/comp items; insider control concentration risk highlighted
Other event disclosure with exhibit; no clear material financial impact flagged
FY2025 10-K: revenue $361M (-1.4%), back to net loss, debt restructured via 2029 notes
Q4/FY2025 earnings release; FY revenue -1.4% YoY and net income flipped to -$10.8M
Preliminary results / earnings update issued ahead of full Q4 print
Executive/director change disclosed under Item 5.02 with no severance red flags noted
Sources: SEC EDGAR (CIK 0001114995, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 6/25/2026, 1:13:13 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 8 sales
| 2026-06-23 | Baker Cary CHIEF FINANCIAL OFFICER | Exercise | 479.00 | |
| 2026-06-23 | Baker Cary CHIEF FINANCIAL OFFICER | Exercise | 597.00 | |
| 2026-06-23 | Baker Cary CHIEF FINANCIAL OFFICER | Tax | 424.00 @ $125.22 | $53.1K |
| 2026-06-23 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | Exercise | 1.22K | |
| 2026-06-23 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | Exercise | 1.82K | |
| 2026-06-23 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | Tax | 1.20K @ $125.22 | $150K |
| 2026-06-15 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | Gift | 10.0K | |
| 2026-06-09 | SYLEBRA CAPITAL LLC Director | Sell | 12.1K @ $127.36 | $1.54M |
| 2026-06-08 | SYLEBRA CAPITAL LLC Director | Sell | 12.5K @ $125.97 | $1.58M |
| 2026-06-08 | SYLEBRA CAPITAL LLC Director | Sell | 33.0K @ $130.07 | $4.29M |
| 2026-06-05 | SYLEBRA CAPITAL LLC Director | Sell | 11.6K @ $128.87 | $1.50M |
| 2026-06-05 | SYLEBRA CAPITAL LLC Director | Sell | 35.9K @ $122.50 | $4.39M |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.